Hologic Inc. has scheduled a special stockholders meeting to vote on the proposed merger between the Bedford company and Marlborough-based Cytyc Corp.
The meeting is scheduled for Oct. 18 at 9 a.m. at Hologic’s Bedford headquarters. Hologic and Cytyc entered into the $6.2 billion merger agreement in May. Under the agreement, Cytyc stockholders would receive Hologic common stock and $16.50 in cash for each share of Cytyc common stock owned.
Both companies develop imaging and diagnostic systems for women’s health and cancer screening.